Inflammatory Biomarkers and Carotid Thickness in HIV Infected Patients under Antiretroviral Therapy, Undetectable HIV-1 Viral Load, and Low Cardiovascular Risk

Inflammatory Biomarkers and Carotid Thickness in HIV Infected Patients under Antiretroviral Therapy, Undetectable HIV-1 Viral Load, and Low Cardiovascular Risk

Abstract Background: People living with HIV are at increased risk of cardiovascular disease and carotid thickness, due to the inflammation caused by the virus, the antiretroviral therapy, and other risk factors. However, few studies have observed the occurrence of cardiovascular diseases and caroti...

Full description

Bibliographic Details
Main Authors:	Kaliene Maria Estevão Leite, Gerson Gomes Santos Júnior, Emmanuelle T. A. M Godoi, Adriana Ferraz Vasconcelos, Virgínia Maria Barros Lorena, Paulo Sérgio Ramos Araújo, Kledoaldo Oliveira Lima, Heloisa Ramos Lacerda
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Cardiologia (SBC) 2019-10-01
Series:	Arquivos Brasileiros de Cardiologia
Subjects:	HIV HIV Infections Cardiovascular Diseases Antiretroviral Therapy Risk Factors Caroti Artery Diseases Atherosclerosis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2020000100090&tlng=pt

Similar Items

Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco
by: Ana Maria Salustiano Cavalcanti, et al.
Published: (2012-06-01)

Grayscale Ultrasound Texture Features of Carotid and Brachial Arteries in People With HIV Infection Before and After Antiretroviral Therapy
by: Christina M. Hughey, et al.
Published: (2022-03-01)

A Retrospective Propensity‐Matched Analysis of Functional Outcomes for Carotid Puncture for Endovascular Thrombectomy
by: Andrew T. Yu, et al.
Published: (2023-01-01)

Expanding Treatment Opportunities: Reviewing the Current State of Injectable Antiretrovirals for Treatment of HIV
by: Amanda Binkley, et al.
Published: (2024-10-01)

Metabolic syndrome among people living with HIV on antiretroviral therapy in Mwanza, Tanzania
by: Evangelista Malindisa, et al.
Published: (2023-04-01)

Mother‐child dyads living with HIV in the Western Cape, South Africa: Undetectable = Undetectable?
by: Kim Anderson, et al.
Published: (2025-02-01)

Prevalence of periodontitis in young adults living with HIV/Aids using antiretroviral therapy
by: Alexandre Candido da SILVA, et al.
Published: (2023-06-01)

HIV‐associated dysbiosis and immune recovery during antiretroviral therapy
by: Samuel D. Johnson, et al.
Published: (2022-04-01)

Posaconazole: A Review of Drug Interactions with HIV Antiretroviral Agents
by: Mara Poulakos, et al.
Published: (2014-03-01)

Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV
by: Yulan Qing, et al.
Published: (2023-05-01)

Cardiovascular pathology in HIV-infection during antiretroviral therapy
by: Renata G. Tuaeva, et al.
Published: (2024-02-01)

Adherence to antiretroviral therapy among people living with HIV/AIDS in northeastern Brazil: a cross-sectional study
by: Rita de Cassia Albuquerque Soares, et al.
Published: (2020-03-01)

Treated HIV Infection and Progression of Carotid Atherosclerosis in Rural Uganda: A Prospective Observational Cohort Study
by: Mark J. Siedner, et al.
Published: (2021-06-01)

PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
by: V. A. Chibilyaev, et al.
Published: (2015-03-01)

Analysis of the prevalence of dyslipidemia in individuals with HIV and its association with antiretroviral therapy
by: Talita Gabriela de Limas, et al.
Published: (2014-10-01)

Endothelial Glycocalyx Integrity in Treatment-Naïve People Living with HIV before and One Year after Antiretroviral Treatment Initiation
by: Paraskevi C. Fragkou, et al.
Published: (2023-07-01)

Risk of Falls in HIV-Infected Patients on Antiretroviral Therapy and Its Associated Factors
by: Wahyudi ER, et al.
Published: (2022-08-01)

Association of virological control and antiretroviral therapy with a cardiovascular autonomic balance in HIV
by: Naiára Casarin, et al.
Published: (2019-01-01)

Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV
by: Milena M McLaughlin, et al.
Published: (2018-03-01)

Effect of antiretroviral drugs on maternal CD4 lymphocyte counts, HIV-1 RNA levels, and anthropometric parameters of their neonates Efeito das drogas anti-retrovirais sobre os valores dos linfócitos TCD4, RNA do HIV-1 e parâmetros antropométricos de neonatos de gestantes portadoras do HIV-1
by: Patrícia El Beitune, et al.
Published: (2005-06-01)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
by: Charlotte Charpentier, et al.
Published: (2023-02-01)

Mental health of people living with hiv and adherence to antiretroviral therapy
by: F. Goma, et al.
Published: (2021-04-01)

Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV
by: Zhenyan Wang, et al.
Published: (2024-11-01)

A New Combined Antiretroviral Therapy In Adolescents With HIV: Bictegravir/Emtricitabine/Tenofovir Alafenamide
by: Neslihan Mete Atasever, et al.
Published: (2024-12-01)

A study of barriers to adherence of antiretroviral treatment in prisoners living with HIV in Tehran, Iran
by: Seyedahmad Seyedalinaghi, et al.
Published: (2020-06-01)

RISK FACTORS OF HIV-1 VERTICAL TRANSMISSION (VT) AND THE INFLUENCE OF ANTIRETROVIRAL THERAPY (ART) IN PREGNANCY OUTCOME
by: Maria F.M. Barral, et al.
Published: (2014-04-01)

Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy
by: Rocio Jiménez-Galán, et al.
Published: (2016-07-01)

A case of successful treatment with antiretroviral therapy for HIV in a patient with marked liver dysfunction
by: Hirofumi Fukuda, et al.
Published: (2022-11-01)

Depressive features among adult patients receiving antiretroviral therapy for HIV in Rustenburg district, SA
by: T Bongongo, et al.
Published: (2013-06-01)

Monitoring HIV Antiretroviral Therapy via Aptamer‐Based Measurements in Preclinical Animal Models, in Human Plasma
by: Jing Li, et al.
Published: (2025-03-01)

Effect of fatty acid content in the diet on lipid profile in HIV-infected patients treated with antiretroviral drugs
by: Agata Jackiewicz, et al.
Published: (2019-03-01)

Efek Samping Terapi Antiretroviral dan Kepatuhan Berobat Penderita HIV/AIDS
by: Rico Januar Sitorus, et al.
Published: (2021-11-01)

IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION
by: V. B. Denisenko, et al.
Published: (2018-07-01)

HIV Infection, Antiretroviral Drugs, and the Vascular Endothelium
by: Georgette D. Kanmogne
Published: (2024-04-01)

Influence of antiretroviral therapy and cardiovascular disease on the immature platelet fraction in patients living with HIV
by: A. Goedel, et al.
Published: (2020-08-01)

Trends Analysis of HIV Infection and Antiretroviral Treatment Outcome in Amhara Regional from 2015 to 2021, Northeast Ethiopia
by: Addisu T, et al.
Published: (2023-07-01)

Factors associated with antiretroviral therapy adherence among people living with HIV in Haiti: a cross-sectional study
by: Ludentz Dorcélus, et al.
Published: (2021-11-01)

Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa
by: Nivashnee Naicker, et al.
Published: (2022-07-01)

Prevalence of hypoalbuminemia in outpatients with HIV/AIDS
by: José Adalberto Leal, et al.

EFFECT OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ON VAGINAL Candida spp. ISOLATION IN HIV-INFECTED COMPARED TO HIV-UNINFECTED WOMEN
by: Silvia de Souza Dantas ALCZUK, et al.
Published: (2015-04-01)